The firm was founded, as Hyman and; Phelps, on St. Patricks Day in 1980. There were three founders:Paul Hyman, Jim Phelps, and Bob Dormer. They left a New York-based firm to create their own practice. The goal of the new firm was to provide service to clients regulated primarily by the Food and Drug Administration, the agency with which the three founders had extensive experience. When Steve McNamara joined the practice in 1984, the firm became known as Hyman, Phelps and; McNamara. Later that year, the firm incorporated, and has since been known as Hyman, Phelps and; McNamara, P.C. The founders intended to maintain the firm at a size to meet the needs of food and drug clients. Over the years, the size of the firm has grown considerably due to the ever-increasing needs of those clients. As government regulation of the food, dietary supplement, drug, biologic, medical device and cosmetic industries has escalated, our food and drug practice has expanded into many related subspecialties, including controlled substances, fraud and abuse, reimbursement and payor issues, and advertising and claims substantiation, to name a few. (To view a list of our specialty practice areas, see Practice Areas.) The backgrounds and experiences of our attorneys support the breadth of the firms practice. Our attorneys have had experience in many branches of the federal government, including the Food and Drug Administration, the Department of Justice (Office of Consumer Litigation), U.S. Attorneys Offices, the Drug Enforcement Administration, and Centers for Medicaid and Medicare Services. Two of our attorneys have been general counsels in major pharmaceutical houses, and others have served in industry trade associations. Still others have scientific backgrounds in areas that complement our practice, such as clinical research and the practice of pharmacy. One member is a former judge, and several were law clerks. (To view the individual biographies, see Professionals ). Together the firms attorneys bring a seasoned focus to the issues that confront food, dietary supplement, drug, biologic, medical device, and cosmetic companies.
This article uses content from
http://www.AboutUs.org
